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ABSTRACT
Takayasu’s arteritis (TA) is a nonspecific, chronic and stenotic panarteritis which usually involves the aorta and its major br-
anches. Corticosteroid and immunosuppressants are recommended to manage the acute inflammatory phase, but their long 
term benefits are uncertain. Blood pressure (BP) control during the chronic phase of TA is essential to preserve renal function, 
which is associated with the patient’s long-term prognosis and survival. Revascularization in organ damaging arterial stenosis 
with percutaneous angioplasty (PTA)/stenting or bypass surgery have been accepted as established treatment options in chron-
ic complicated phase of TA. We present a case of a 31-year-old female patient with a two-day history of sudden onset oliguria 
and generalized edema whose acute oliguric renal failure was successfully reversed following PTA and stenting in a solitary 
functioning kidney with critical renal artery stenosis (RAS) caused by TA. (Korean Circ J 2010;40:414-417)
KEY WORDS: Angioplasty; Acute renal failure; Renal artery stenosis; Takayasu arteritis.
Received: January 5, 2010
Revision Received: January 26, 2010
Accepted: January 27, 2010
Correspondence: Jang-Whan Bae, MD, Division of Cardiology, Depart-
ment of Internal Medicine, Chungbuk National University School of Medi-
cine, 62 Gaesin-dong, Heungdeok-gu, Cheongju 361-763, Korea
Tel: 82-43-269-6011, Fax: 82-43-273-3252
E-mail: drcorazon@hanmail.net
cc This is an Open Access article distributed under the terms of the Cre-
ative Commons Attribution Non-Commercial License (http://creativecom-
mons.org/licenses/by-nc/3.0) which permits unrestricted non-commer-
cial use, distribution, and reproduction in any medium, provided the ori-
ginal work is properly cited.
Introduction
Takayasu’s arteritis (TA) frequently affects the ascending 
aorta and aortic arch, causing obstruction of the aorta and its 
major arteries. The pathology is a panarteritis, characterized 
by mononuclear cells and occasionally giant cells infiltration, 
with marked intimal hyperplasia, medial and adventitial th-
ickening, and, in the chronic form, fibrotic occlusion.
1) Medical 
therapy with corticosteroids and immunosuppressants is ge-
nerally recommended in active inflammatory phase of TA.
1) 
Renal artery stenosis (RAS) is observed in the 38-40% of an-
giographically confirmed TA patients.
2)3) The disease progress 
of RAS is directly associated with the aggravation of hyper-
tension and renal function deterioration, therefore RAS con-
stitutes a main prognostic factor of TA.
4) Percutaneous angio-
plasty (PTA) and stenting in the context of acute oliguric renal 
failure due to severe RAS in a solitary functioning kidney when 
the function of the contralateral kidney had been completely 
lost due to renal artery (RA) occlusion in TA is rarely report-
ed in the literature.
5) We present a patient who developed acute 
oliguric renal failure due to severe RAS in a solitary function-
ing kidney successfully treated with PTA and stenting. 
Case
A 31-year-old female was referred to our institution with a 
two-day history of acute onset generalized edema and oliguria. 
Her vital signs were as follows: blood pressure (BP): 170/110 
mmHg, pulse rate: 76/minute, respiratory rate: 23/minute, 
body temperature: 36.7℃. On examination, she appeared 
swollen and pre-tibial pitting edema was evident. Mild crack-
les were appreciated in the lower lung fields. The patient had 
been admitted to our institution 9 years ago for investigation 
of BP inequality (240/160 mmHg in left arm, 140/70 mmHg in 
right arm). At that time, an abdominal aortic bruit was audible 
and erythrocyte sedimentation rate (ESR) was elevated up to 





Fig. 1. Left kidney was not enhanced due to chronic complete occlusion of the left RA. Severe stenosis of right RA was treated with PTA and 
stenting under the “no-touch technique”. A: left RA was totally occluded and the kidney was not enhanced. Near complete occlusion of right RA 
was visualized on abdominopelvic CT. B: severe stenosis of right RA was confirmed by renal angiography. C: PTA was performed to right RA 
under the “no-touch” technique. D: the lesion was successfully dilated after stent implantation without complications (arrows indicate critical 
right RA stenosis in abdominopelvic CT and renal angiography). RA: renal artery, CT: computed tomography, PTA: percutaneous angioplasty.
thin the normal range. Given the high suspicion for RAS, we 
performed a Technetium
99m-Diethylene Triamine Pentaacetic 
Acid (Tc
99m-DTPA) renal scan, which demonstrated severely 
reduced left kidney function. RAS was confirmed with addi-
tional captopril renal scan and captopril challenge test. The pa-
tient’s left RA was almost completely occluded and the right 
RA was normal on angiography. The patient was recommend-
ed to undergo left RA bypass surgery and corticosteroid thera-
py, but she declined surgery and was discharged with oral cor-
ticosteroids and antihypertensives. The patient was investi-
gated again four years ago with a three-day history of gene-
ralized edema and reduced urine output, followed by vomiting 
and diarrhea secondary to gastroenteritis for one week. Her 
Cr at that time was elevated up to 14.7 mg/dL but subsequent-
ly returned to 1.8 mg/dL following hemodialysis. She con-
tinued to refuse bypass surgery. Despite these two episodes, 
she remained well on medical therapy at a local clinic, and her 
Cr recorded at a local laboratory was 1.9 mg/dL two weeks 
prior to the latest admission. Her blood chemistry when she 
presented to emergency triage in this time were as follows: 
sodium 128 meq/L, potassium 5.3 meq/L, BUN 84 mg/dL, 
Cr 11.8 mg/dL, C-reactive protein 0.7 mg/dL, and ESR 72 
mm/h. She subsequently underwent emergent hemodialysis 
twice, and her Cr returned to 1.9 mg/dL with recovered urine 
output. Computed tomography (CT) scan of the abdomen and 
pelvis revealed severely contracted and non-functioning left 
kidney due to chronic complete occlusion of the left RA while 
a new, severe, right RAS was noted (Fig. 1A). Angiogram con-
firmed complete left RA occlusion and demonstrated 95% 
stenosis in the proximal portion of the right RA (Fig. 1B). By 
this stage, this patient’s stenotic left RA and normal right RA 
demonstrated 9 years ago had markedly progressed to com-
plete left RA occlusion and severe right RAS, resulting in acute 
oliguric renal failure. Decision was made to perform PTA and 
stenting for the newly diagnosed right RAS, which perfused 
her solitary functioning kidney. She was managed with aspi-
rin and clopidogrel for three days prior to the procedure. Over-
night intraveous saline hydration (1.5 cc/kg/h for 12 hours) 416   PTA for a Solitary Functioning Kidney in TA
and preprocedural intravenous acetlycysteine was prescribed.
6) 
Her Cr was 2.1 mg/dL on the day of procedure. 
The right common femoral artery was punctured and a 7 
Fr. arterial sheath (Cook, Bloomington, IN, USA) was intro-
duced. The 7 Fr. Vista Brite RDC guiding catheter (Cordis, 
Warren, NJ, USA) was adjusted to around the right RA osti-
um to prevent the catheter tip induced renal ostial or aortic 
wall damage. The “no-touch technique” was applied during 
the procedure using a 0.035-inch J curved-Terumo wire (Teru-
mo, Tokyo, Japan) which separated the guiding catheter tip 
from RA ostium and a 0.014-inch Runthrough wire (Terumo, 
Tokyo, Japan) was used to drive interventional devices (Fig. 
1C).
7) The lesion was pre-dilated with a Savvy 3.5×20 mm 
balloon (Cordis, Warren, NJ, USA) at 12 atm (3.81 mm). A 85% 
residual stenosis was observed after the pre-dilation. A Gen-
esis 7×24 mm balloon expandable stent (Cordis, Warren, NJ, 
USA) was implanted with nominal pressure and ostial stent 
flaring was performed at 16 atm (7.30 mm) for 15 seconds. 
A residual stenosis of 50% was noticed in the main stenotic 
area. The procedure was completed after Amiia 6.0×20 mm 
balloon (Cordis, Warren, NJ, USA) inflation at 12 atm (5.12 
mm). The final angiogram showed acceptable lesion dilation 
without complication. (Fig. 1D) A total of 120 cc of Visipaque 
(GE Healthcare, Princeton, NJ, USA) was used. Postproce-
dural hemodialysis was performed for 2 hours.
8) Patient was 
discharged after 2 days with dose-reduced antihypertensives 
and prednisolone. Her pre-discharge Cr was 1.7 mg/dL. The 
patient currently remains well with a Cr in the normal range 
11 months following hospitalization. 
Discussion
RAS related renal failure and poorly controlled hyperten-
sion should be treated by revascularization. PTA is generally 
accepted as a less invasive, efficacious and safe treatment mo-
dality compared to surgical bypass, which is associated with 
higher morbidity.
9) There are some published data demon-
strating satisfactory results with PTA in treatment of TA in-
duced RAS. Sharma et al.
10) reported that PTA with or with-
out stenting is a safe and efficacious modality to relief stenotic 
lesion in 20 patients with TA in a study with at least 6 months’ 
follow-up. Tanaka et al.
11) examined the efficacy of conven-
tional balloon angioplasty and cutting balloon angioplasty 
for the treatment of non-arteriosclerotic RAS in 20 patients. 
We chose PTA as a first line treatment option for several rea-
sons in our patient. First, she adamantly refused bypass sur-
gery. Secondly, PTA was not inferior to surgical bypass as a 
treatment modality to control hypertension and preserve re-
nal function in RAS.
9) To minimize contrast induced nephrop-
athy, we administrated sufficient amounts of saline and acet-
ylcysteine before the procedure and used the iso-osmolar con-
trast agents followed by hemodialysis after intervention based 
on previous recommendations in the medical literature.
6)8)12) 
The usefulness of distal protection device or carbon dioxide 
angiography in renovascular intervention has been contro-
versial and we chose not employ them for our patient.
13)14) Long 
term complications of PTA/stenting include restenosis, throm-
botic occlusion, stent fracture and migration. If BP elevation 
or renal function deterioration occurs during follow-up, arte-
rial patency should be examined with Duplex ultrasound, mag-
netic resonance, CT or selective angiography. This patient had 
originally been managed with four types of antihypertensive 
medications: nifedipine 66 mg bid, atenolol 50 mg qd, losar-
tan 50 mg qd, and furosemide 40 mg qd at the time of admis-
sion, but only nifedipine 66 mg bid was required after PTA/
stenting. At her follow up 11 months post-procedure, her Cr 
level was maintained within the normal range. Our patient is 
doing well following RA PTA and stenting against the back-
ground of acute oliguric renal failure due to TA induced criti-
cal RAS in a solitary functioning kidney. However, the optimal 
use of RA revascularization is poorly defined and the exact 
indications and clinical applications of RA revascularization in 
RAS are evolving.
15) When making clinical decisions on renal 
revascularization one must assess the severity and functional 
significance of RAS (renal ischemia), the condition of the kid-
neys (nephropathy) and the association between RAS and 
vital organ injury.
15) The risks and benefits of RA PTA will be 
improved by careful patient selection.
15) Better results will be 
achieved in patients with vital organ injury, renal ischemia 
in the absence of nephropathy. Given the limited clinical tri-
al outcomes and observational case reports, PTA and stenting 
should be considered a safe and efficacious treatment modal-
ity for TA induced acute renal failure due to RAS in a solitary 
functioning kidney.
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